JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M709549200 on March 31, 2008

J. Biol. Chem., Vol. 283, Issue 22, 15258-15270, May 30, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/22/15258    most recent
M709549200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Kim, Y.-I.
Right arrow Articles by Yi, A.-K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y.-I.
Right arrow Articles by Yi, A.-K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

CpG DNA Prevents Liver Injury and Shock-mediated Death by Modulating Expression of Interleukin-1 Receptor-associated Kinases*Formula

Young-In Kim{ddagger}1, Jeoung-Eun Park{ddagger}2, Antonio Martinez-Hernandez§, and Ae-Kyung Yi{ddagger}||3

From the {ddagger}The Children's Foundation Research Center at Le Bonheur Children's Medical Center and the Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee 38103, the §Department of Pathology and Laboratory Medicine and ||Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163, and Pathology and Laboratory Medicine Service, Veteran Affairs Medical Center, Memphis, Tennessee 38104

Tumor necrosis factor-{alpha} (TNF-{alpha}) produced by macrophages in response to CpG DNA induces severe liver injury and subsequent death of D-galactosamine (D-GalN)-sensitized mice. In the present study we demonstrate that mice pre-exposed to CpG DNA are resistant to liver injury and death induced by CpG DNA/D-GalN. CpG DNA/D-GalN failed to induce TNF-{alpha} production and hepatocyte apoptosis in the mice pre-exposed to CpG DNA. In addition, macrophages isolated from the CpG DNA-pretreated mice showed suppressed activation of MAPKs and NF-{kappa}B and production of TNF-{alpha} in response to CpG DNA, indicating that the CpG DNA-mediated protection of CpG DNA/D-GalN-challenged mice is due to the hyporesponsiveness of macrophages to CpG DNA. CpG DNA pretreatment in vivo inhibited expression of interleukin-1 receptor-associated kinase (IRAK)-1 while inducing IRAK-M expression in macrophages. Suppressed expression of IRAK-1 was responsible for the macrophage hyporesponsiveness to CpG DNA. However, increased expression of IRAK-M was not sufficient to render macrophages hyporesponsive to CpG DNA but was required for induction of the optimal level of macrophage hyporesponsiveness. Taken together, reduced expression of IRAK-1 and increased expression of IRAK-M after CpG DNA pretreatment resulted in the hyporesponsiveness of macrophages that leads to the protection of mice from hepatic injury and death caused by CpG DNA/D-GalN.


Received for publication, November 21, 2007 , and in revised form, February 7, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grant AI053137 (to A.-K. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1 and Figs. 1–6.

1 Supported by a postdoctoral fellowship from the Korea Research Foundation (KRF-2005-214-E00045) and a grant from Le Bonheur Children's Medical Center.

2 Supported by a grant from Le Bonheur Children's Medical Center.

3 Supported by grants from the Musette and Allen Morgan, Jr. Foundation^M for the Study of Primary Sclerosing Cholangitis and by the Children's^M Foundation of Memphis

3 To whom correspondence should be addressed: Dept. of Pediatrics, University of Tennessee Health Science Center, 50 N. Dunlap St., Rm. 315 WPT, Memphis, TN 38103. Tel.: 901-287-4475; Fax: 901-287-5036; E-mail: ayi{at}utmem.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J.-E. Park, Y.-I. Kim, and A.-K. Yi
Protein Kinase D1: A New Component in TLR9 Signaling
J. Immunol., August 1, 2008; 181(3): 2044 - 2055.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.